Health Care · Biological Products, (No Diagnostic Substances) · OTC · CIK 1137883 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $1.22 · Day −13.48% · Mkt cap $16M · 1Y +87.7% · Off 52W high −27.8% · Vol (1Y) 97.9% Price2023-08-21 → 2026-08-19 BCLI close: $22.4 on 2023-08-21 to $1.2 on 2026-08-19. Split-adj closes · 240 of 2,541 · price returnⓘ At a glance | Short interest0.4% of sh out | | Days to cover2.5d | | Next report (est.)2026-11-14 |
SI 2026-07-31ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+121.8% | | 1Y+87.7% | | 3Y−94.6% | | 5Y−97.5% | | 10Y−96.7% | | Since incept. (ann.)−28.8% |
Total return · from 2016-07-11ⓘ Risk | Ann. volatility (1Y)97.9% | | Ann. volatility (3Y)122.6% | | Sharpe (1Y)1.17 | | Sharpe (3Y)−0.16 | | Max drawdown (1Y)−47.2% | | Max drawdown (3Y)−98.1% | | Beta (3Y vs SPY)2.32 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for BCLI. Latest reported quarterslast report 2026-08-14 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-14 | −$0.35 | — | — | — | | 2026-03-31 | 2026-05-15 | −$0.19 | — | — | — | | 2025-09-30 | 2025-11-14 | −$0.19 | — | — | — | | 2025-06-30 | 2025-08-14 | −$0.34 | — | — | — |
As-reported XBRL · next 2026-11-14 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
